MiR-101-3p targets the PI3K-AKT signaling pathway via Birc5 to inhibit invasion, proliferation, and epithelial–mesenchymal transition in hepatocellular carcinomaWen‐Yuan Zhu, Chang Hong|Clinical and Experimental Medicine|2025Cited by 10